Worldwide HealthcareWWH:LSE

1,855
22.00 / 1.17 %
46.25k
27.93%
0.5667
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Sep 02 2015 17:15 BST.

Total returns on £1000

Fund / BenchmarkChange
PriceWorldwide Healthcare (Ordinary Share)+30.33 %
Worldwide Healthcare (Ordinary Share)+25.18 %
Morningstar's BenchmarkFTSE World+2.65 %
As of Sep 01 2015.

Worldwide Healthcare summary

Shares outstanding47.83m
Market cap892.00m GBP
Total assets1.03bn GBP
Total expense ratio1.01%
Day high1,875
Day low1,850
Previous close1,877
Average volume108.63k
YTD Change+8.26 %
Beta0.5667%
Diluted NAV (est)1,902.72
Diluted NAV (last pub)1,976.19
Premium/Discount-2.51 %
Gearing+114.00 %
52-week range
Today
1,355
Oct 15 2014
2,108.5
Jul 21 2015

On Wednesday, WWH:LSE closed at 1,855, 12.02 % below its 52-week high of 2,108.5, set on Jul 21, 2015.

Data delayed at least 15 minutes, as of Sep 02 2015 17:15 BST.

Profile

Management group(s)OrbiMed Capital LLC
AIC sectorSector Specialist: Biotechnology/Life Sciences
ISINGB0003385308
Launch date28 Apr 1995
Share typeOrdinary Share
StructureConventional
Base currencyGBP

Objective

To invest worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.

Management & contract fees

The Investment Manager, receives a periodic fee equal to 0.65% p.a. of the Company's net asset value. The performance fee amounts to 16.5% of any out-performance of the NAV over the benchmark index.

Dividend

Div yield0.73995
Div ex-date11 Jun 2015
Div pay-date14 Jul 2015

Managed by

Sven Borho Start : 01 Feb 2013
Samuel. D Isaly Start : 28 Apr 1995
Data delayed at least 15 minutes, as of Sep 02 2015 17:15 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.